Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

PRE-703 moved to project status in anxiety

April 8, 2002

First patients enrolled in trial of Ampakine CX-516 in mild cognitive impairment

April 8, 2002

Glutamate receptor function potentiators designed by Lilly

April 8, 2002

KRP-199: a highly potent, selective and water-soluble AMPA receptor antagonist

April 8, 2002

Phase I ADL-10-0101 program expanded

April 5, 2002

Paxil CR launch date set

April 5, 2002

Combinations of morphine, clonidine and cholinesterase inhibitors examined in rat formalin test

April 5, 2002

Novel compounds patented by Brigham & Women's for use in Alzheimer's disease

April 5, 2002

Novel peptides inhibit interaction of Abeta with alpha7 nicotinic receptors

April 4, 2002

AlgoRx completes acquisition of PowderJect's drug business

April 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.